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OXYGENATION STATUS IN PRIMARY SQUAMOUS CELL
CARCINOMAS OF HEAD AND NECK
H.J\ Feldmann, D.M. Saumweber1, Th. Auberger, W  Arnold , M . Molls 
Department o f Radiation Oncology
1 Department of E N T  surgery, Technische Universität München, Klmikum  
rechts der Isar; 81675 München, G«rma»j>
45 patients with primary head and neck tumors were investigated 
pretherapeutically. In 30 patients the tumors were located at the floor 
of the mouth, the tongue or the tonsil. In these cases pÜ2 measurements 
were performed in general anesthesia during endoscopic procedure. In
15 patients large neck nodes (N2/N3) were investigated pretherapeuti­
cally and during split course radio chemotherapy. In general, the me­
dian pÜ2 distribution ranged between 2.4 and 46.6 mmHg and showed 
marked tumor to tumor heterogeneity. The follow up investigations dur­
ing split course radio chemotherapy (n = 15) showed a significant increase 
of the median p0 2 after the pause. The observed changes of tumor oxy­
genation during therapy will be discussed in detail with regard to their
clinical relevance.
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HYPERTHERMIA-ENHANCED EFFECTIVENESS OF 
CISPLATIN IN UNTREATED VERSUS IRRADIATED RAT 
SOLID TUMOURS
C. van Breef, R.C. Rietbroeki2, J.B.A. Kipp13 P,J,M. Bakker2> 
C.H.N. Veenhofi
1 Department of Radiotherapy
2Medical Oncology, Academic Medical Centre, BO. Box 22700, 1100 DE  
Amsterdam, The Netherlands
Hyperthermia (HT) enhances cytotoxicity of cisplatin (CDDP). If this 
enhancement is different in untreated versus irradiated tumours is not 
known. Therefore this animal study investigates the efficacy of com­
bined CDDP and HT in untreated tumours compared to tumours re- 
g rowing after irradiation.
Pieces of R-l rhabdomyosarcoma were subcutaneously implanted in 
the hind legs of Wag/Ry rats. After irradiation the tumours regrew
to their original volumes within 16 days. Chemo-hyperthermic treat
ment of untreated tumours or irradiated tumours at day 16 after irrarii" 
ation consisted of CDDP (6 mg/kg ip), HT (1 h at 43°C) or CDDp + 
HT (45 min interval). The experimental endpoint was tumour growth 
delay (TGD). In untreated tumours CDDP + HT resulted in a signifi­
cantly larger TGD than CDDP alone (11.6 and 7.4 days respectively? 
= 0.0002), while HT alone showed a 1-day TGD. Preliminary results'in 
irradiated tumours indicate that CDDP + HT rendered a similar TGD 
as in untreated tumours, although the TGD after CDDP + HT was not 
significantly different from CDDP alone.
Our findings show that HT enhances the effectiveness of CDDP in 
R -1 tumours. Untreated tumours probably respond similar to CDDP + 
HT as compared to irradiated tumours.
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CONTINUOUS VS. SPLIT-COURSE IRRADIATION FOR LUNG 
CANCER. IMMUNOLOGICAL IMPLICATIONS
L j. Vuckovic-Dekic , N. Stanojev ic~B a k ic, M . Dekic, O. Prim 
Institute for Oncology and Radiology o f Serbia, Institute of Radiology, Mil­
itary Medical Academy, 11000 Beograd, Yugoslavia
The therapeutic irradiation for lung cancer causes profound disturbances 
of host’s general immunocompetence, the cellular immunodépression 
being the dominant finding. It is thought that the spiit-course tech­
nique holds certain advantage over the continuous irradiation, since the 
former includes a period of 4 weeks between two courses, thus allowing 
the lymphopoeitic system to recover to a certain degree. In this report, 
we compared the radiotherapy-due alterations of several cellular immu­
nity parameters (the number and function of total T cells, active T cells 
and the cells of monocyte/macrophage lineage), immediately after the 
completion of either continuously (n = 13) or split course-irradiated (?i 
= 12) lung cancer patients. All patients had received the total dose of 
60 Gy. Both therapeutical techniques caused alterations of the param­
eters tested: the significant decrease of the total and active T cells and 
their lymp ho proliferative response, while the phagocyting activity and 
the number of mononuclear phagocytes were increased, the latter being 
affected to a lesser extent in split-course-treated patients. Our results 
suggest that both techniques have similar immunodepressant effect on 
the cellular immunity of lung cancer patients,
Soft tissue sarcomas
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FIRST CLINICAL EXPERIENCE WITH A GROWING 
ENDOPROSTHESIS, A LIMB SAVING PROCEDURE IN 
CHILDREN (FILM—10 MIN)
H  Schraffordt Koops, GJ, Verkerke, R.P. Veth, J.R. v. Horn, A. Postma, 
H.J. Grootenboer
University Hospital Groningen, The Netherlands 
Purpose of the study: To perform the first clinical study with an extend­
able endoprosthesis that can be extended non-invasively for children 
with a malignant bone tumor in the leg.
Method: A 14-year old boy had an osteosarcoma at the distal 
metaphysis of the femur. The patient was first treated successfully 
by chemotherapy (cisplatin, doxorubicin, ifosfamide and high dose 
methotrexate). The operation followed a few weeks after chemother­
apy courses. Enough muscle tissue could be preserved. Resection was 
followed by reconstruction with a new extendable modular endopros- 
thetic system. The growing endoprosthesis is powered magnetically An 
electromagnet, rotating outside the leg, produces a magnetic field that 
causes rotation of a small permanent magnet in the prosthesis. The mag­
net drives a motion screw via a gearbox. When the motion screw rotates 
the inner and outer tube of the prosthesis are forced apart.
Results: Seven months after the operation there was a leg length dis­
crepancy of 20 mm. The first extension was performed and resulted in
2 mm growth. Anaesthesia was not necessary. X-rays prior to and af­
ter the lengthening procedure were taken to demonstrate the increase in 
length of the endoprosthesis. Six weeks later the second extension of 
5 mm was performed successfully. Further extensions of 5 mm will be
repeated every one or two months to adjust the discrepancy in length of 
both legs.
Conclusions: The first clinical experience with a growing endopros­
thesis seems to be successful. The patient regained almost normal func­
tioning of his leg. Future extensions will prevent a leg length difference.
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10 YEARS EXPERIENCE OF ADJUVANT RADIATION 
THERAPY FOR LOCALISED ADULT SOFT TISSUE SARCOMAS
£  Delaloge1, C. Le Pcchoux1, J. C. B u zz i2, P. Fontaine1
departm en t o f Radiation Oncology 
2Department o f Statistics, IG R , Villejuif, France 
Between January 1984 and December 1993, 119 adult patients (68 males 
and 51 females, median age 42.5 years) were treated at our institute for 
localised sarcoma of extraviscera 1 soft tissue, by maximal conservative 
surgery followed by adjuvant radiation therapy. 30% had previously 
undergone surgery and relapsed. Sites affected were the extremities 
(63.5%), trunk wall (13%), retroperitoneum (9%) and head and neck 
(4%). Predominant histologies were MFH (27%) and Synovialosar- 
coma (19%). 85% of tumors were grade 2 or 3. Thirty-seven patients 
(31%) received chemotherapy, In 75% of the cases, radiation therapy 
was performed using standard techniques and doses of at least 45 y 
Bifractionated radiotherapy (dose 45 Gy) was used for patients treate 
between 1989 and 1992(25%).
Treatment evaluation was performed on 1st March, 1995. Median 
follow-up is 66 months. 24% of the patients relapsed locally, and 4/ /o
